Key Financial Data Of Group

KYORIN Pharmaceutical Co., Ltd. - Filing #7298873

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2023-09-30
2023-04-01 to
2023-09-30
Key financial data of group
Business results of group
Net sales
55,139,000,000 JPY
119,532,000,000 JPY
54,937,000,000 JPY
Ordinary profit (loss)
2,050,000,000 JPY
6,822,000,000 JPY
1,578,000,000 JPY
Profit (loss) attributable to owners of parent
1,255,000,000 JPY
5,475,000,000 JPY
1,890,000,000 JPY
Comprehensive income
1,152,000,000 JPY
8,102,000,000 JPY
2,442,000,000 JPY
Net assets
130,027,000,000 JPY
130,735,000,000 JPY
126,158,000,000 JPY
Total assets
178,865,000,000 JPY
177,627,000,000 JPY
176,102,000,000 JPY
Basic earnings (loss) per share
21.86
95.41
32.97
Diluted earnings per share
Equity-to-asset ratio
0.727 xbrli:pure
0.736 xbrli:pure
0.716 xbrli:pure
Net cash provided by (used in) operating activities
3,379,000,000 JPY
1,549,000,000 JPY
8,364,000,000 JPY
Net cash provided by (used in) investing activities
-5,235,000,000 JPY
-3,187,000,000 JPY
327,000,000 JPY
Net cash provided by (used in) financing activities
1,987,000,000 JPY
-3,347,000,000 JPY
-2,020,000,000 JPY
Cash and cash equivalents
14,017,000,000 JPY
13,886,000,000 JPY
25,584,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.